SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DesertRat1 who wrote (122892)11/14/2003 12:43:48 PM
From: Taki  Read Replies (1) of 150070
 
In VRDE first time profitable in history wow, (BSNS WIRE) Veridien Corporation Breaks into Black; Third Quarter 2003 Net In
ome Reported; Sales up 233%
Veridien Corporation Breaks into Black; Third Quarter 2003 Net Income Reported;
ales up 233%


Health/Medical Writers / Business Editors

ST PETERSBURG, Fla.--(BUSINESS WIRE)--VRDE--
Veridien Corporation (OTCBB:VRDE) reported Third
Quarter (2003) Net Income of $126,134 compared to a Net Loss of
$55,682 in Q3 2002. This is the first quarter in Veridien's reporting
history that its Net Income has been positive.
Compared to the third quarter 2002, performance for the third
quarter 2003 included a sales increase of 233%, improvement in gross
margins from 31% to 54%, reduction in operating loss from $254,833 to
$152,402 and increase in Other Income from $199,151 to $278,536.
Year to date Sales to September 30, 2003 are $1,300,669, 189% of
year-to-date sales for the same period last year.
Veridien Corporation's President & C.E.O. Sheldon C. Fenton said:
"The efforts we have made in expanding our sales base with our
strategic partners and improving our margins are evident in our
financial results. We plan to continue to build on these successes. We
are gratified to report a positive Third Quarter Net Income."

About Veridien

Veridien Corporation is a Health Care Company focusing on
Infection Control and other Healthy Lifestyle products. Veridien has
developed PATENTED and UNIQUE PRODUCTS including SURFACE
DISINFECTANTS, ANTISEPTIC HAND CLEANSERS, INSTRUMENT PRESOAK, AND SUN
PROTECTANT PRODUCTS. The flagship product Viraguard(R) Hospital
Disinfectant/Cleaner and Instrument Presoak is a skin friendly,
patented, U.S. - EPA and Health Canada registered, surface
disinfectant. Viraguard(R) Hospital Surface Disinfectant Towelettes
and Viraguard(R) Toilet Seat Wipes (Sit Secure(TM) program) are also
U.S.-EPA registered. Viraguard(R) Antiseptic Hand Gel, Viraguard(R)
Antiseptic Hand Spray and Viraguard(R) Antiseptic Hand Wipes are all
U.S.- FDA and Health Canada drug listed products utilizing Veridien's
patented Virahol(R) formulation.
Look for Veridien at veridien.com

Special Note: Forward-looking statements in this press release are
made pursuant to the "safe-harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that
such forward-looking statement involve risks and uncertainties,
including without limitation, market acceptance of, and demand for,
the Company's products, manufacturing, development and distributor
issues, product pricing, competition, funding availability,
technological changes and other risks not identified herein. The
Company disclaims any intent or obligation to update any
forward-looking statements.

"Healthy Living is an Adventure - Let Veridien Guide You"



KEYWORD: NEW YORK FLORIDA
INDUSTRY KEYWORD: CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD ADVER
ISING/MARKETING MEDICAL GOVERNMENT SPORTS CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD
ARNINGS
SOURCE: Veridien Corporation


CONTACT INFORMATION:
Veridien Corporation, St. Petersburg
Cheryl Ballou, 727-576-1600 ext 202
cballou@veridien.com

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext